RESISTENSI Mycobacterium Tuberculosis TERHADAP OBAT ANTI TUBERKULOSIS

Authors

  • A. Nikmawati
  • Windarwati Windarwati
  • Hardjoeno Hardjoeno

DOI:

https://doi.org/10.24293/ijcpml.v12i2.843

Keywords:

mycobacterium tuberculosis, tuberculosis, mono-resistant, poly resistant, MDR-TB

Abstract

Patients infected with resistant Mycobacterium tuberculosis strain will be very difficult to cure by standard treatment. To evaluate
the drug resistance of Mycobacterium tuberculosis. A Cross sectional study was performed from January until July 2005. Samples were
obtained from sputum of the suspect tuberculosis. All samples were cultured in Lowenstein-Jensen Media and followed by sensitivity test
according to resistance ratio method. Of 236 samples, there were 30% positive cultures. The percentage of mono-resistance to Isoniazid
was 70%, to Rifampicin 64.3%, to Ethambutol 62.8% and Streptomycin 64.3%. The percentage of Multi Drug Resistant Tuberculosis
(MDR-TB) was 20–40% and the percentage of poly-resistant (Ethambutol and Streptomycin) was 47.1%. The percentage of suspect
tuberculosis with positive culture was 30%. There were also found high percentage of mono-resistant, poly-resistant and MDR-TB.

Downloads

Download data is not yet available.

Downloads

Submitted

2018-03-13

Accepted

2018-03-13

Published

2018-03-14

How to Cite

[1]
Nikmawati, A., Windarwati, W. and Hardjoeno, H. 2018. RESISTENSI Mycobacterium Tuberculosis TERHADAP OBAT ANTI TUBERKULOSIS. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 12, 2 (Mar. 2018), 58–61. DOI:https://doi.org/10.24293/ijcpml.v12i2.843.

Issue

Section

Articles